CAVENEE, WEBSTER,FURNARI, FRANK,JOHNS, TERRANCE GRANT,SCOTT, ANDREW
申请号：
CA2680854
公开号：
CA2680854C
申请日:
2008.03.14
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to the treatment of EGFR-mediated disease, particularly cancer by inhibiting or blocking EGFR and src in combination or simultaneously. The invention relates to treatment, prevention, or modulation of cancer, particularly EGFR- mediated disease, with one or more EGFR modulator and src inhibitor in combination. The invention further relates to the treatment of cancer with anti-EGFR antibodies and src inhibitors. Methods and compositions for treatment of cancer with the antibody anti- EGFR mAb806 in combination or series with a src inhibitor or src inhibitors are described.
